Work

Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits

Year: 2022

Type: article

Abstract: 0.001) groups. Cefiderocol is highly active in treatment of experimental S. maltophilia pneumonia, laying the foundation for future clinical investigations against this lethal infection in immunocompromised patients.

Source: Antimicrobial Agents and Chemotherapy

DOI: 10.1128/aac.00618-22

Authors: Vidmantas Petraitis, Ruta Petraitiene, Povilas Kavaliauskas, Ethan Naing, Andrew Garcia, Benjamin N. Georgiades, Roger Echols, Robert A. Bonomo, Yoshinori Yamano, Michael J. Satlin, Thomas J. Walsh

Institutions: Cornell University, Weill Cornell Medicine, Shionogi (United States), Louis Stokes Cleveland VA Medical Center, Case Western Reserve University, Shionogi (Japan)

Language: English

Topic: Infections and bacterial resistance

Subfield: Endocrinology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4297221340

FWCI: 2.945

Cites: 37

Cited by: 27

Related to: 10